Journal
CANCER CELL
Volume 3, Issue 6, Pages 589-601Publisher
CELL PRESS
DOI: 10.1016/S1535-6108(03)00133-8
Keywords
-
Categories
Funding
- NCI NIH HHS [P01 CA072006-08, CA 72006, P01 CA072006] Funding Source: Medline
- NHLBI NIH HHS [P01 HL066105, HL 66105] Funding Source: Medline
- NIDDK NIH HHS [R01 DK081576, R01 DK055001, DK 51711, R01 DK051711-03, DK 55001, R01 DK055001-02] Funding Source: Medline
Ask authors/readers for more resources
We demonstrate a physiological role for tumstatin, a cleavage fragment of the alpha3 chain of type IV collagen (Col IValpha3), which is present in the circulation. Mice with a genetic deletion of Col IVa3 show accelerated tumor growth associated with enhanced pathological angiogenesis, while angiogenesis associated with development and tissue repair are unaffected. Supplementing Coll IValpha3-deficient mice with recombinant tumstatin to a normal physiological concentration abolishes the increased rate of tumor growth. The suppressive effects of tumstatin require alphaVbeta3 integrin expressed on pathological, but not on physiological, angiogenic blood vessels. Mice deficient in matrix metalloproteinase-9, which cleaves tumstatin efficiently from Col IValpha3, have decreased circulating tumstatin and accelerated growth of tumor. These results indicate that MMP-generated fragments of basement membrane collagen can have endogenous function as integrin-mediated suppressors of pathologic angiogenesis and tumor growth.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available